Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder.
Study design not specified in the source record · PLoS One · 2017. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder.
Chung SD, Kao LT, Lin HC et al.
PLoS One · 2017
- PubMed ID
- 28253340
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.